Comparison of kidney allograft survival in the Eurotransplant senior program after changing the allocation criteria in 2010—A single center experience
Aims: The European Senior Program (ESP) aims to avoid waiting list competition between younger and elderly patients applying for renal transplantation. By listing patients ≥65 years on a separate waiting list and locally allocating of grafts ≥65 years exclusively to this cohort, waiting and cold isc...
Verfasser: | |
---|---|
FB/Einrichtung: | FB 05: Medizinische Fakultät |
Dokumenttypen: | Artikel |
Medientypen: | Text |
Erscheinungsdatum: | 2020 |
Publikation in MIAMI: | 04.04.2022 |
Datum der letzten Änderung: | 04.04.2022 |
Angaben zur Ausgabe: | [Electronic ed.] |
Quelle: | PLoS ONE 15 (2020) 7, e0235680, 1-16 |
Schlagwörter: | Graft survival; Medical dialysis; Renal transplantation; Creatinine; Diabetes mellitus; Ischemia; Surgical and invasive medical procedures; Geriatric care |
Fachgebiet (DDC): | 610: Medizin und Gesundheit |
Lizenz: | CC BY 4.0 |
Sprache: | Englisch |
Förderung: | Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster). |
Format: | PDF-Dokument |
URN: | urn:nbn:de:hbz:6-24049617350 |
Weitere Identifikatoren: | DOI: 10.17879/24049618455 |
Permalink: | https://nbn-resolving.de/urn:nbn:de:hbz:6-24049617350 |
Verwandte Dokumente: |
|
Onlinezugriff: | 10.1371_journal.pone.0235680.pdf |
Aims: The European Senior Program (ESP) aims to avoid waiting list competition between younger and elderly patients applying for renal transplantation. By listing patients ≥65 years on a separate waiting list and locally allocating of grafts ≥65 years exclusively to this cohort, waiting and cold ischemia times are predicted to be shortened, potentially resulting in improved kidney transplantation outcomes. This study compared a historic cohort of renal transplant recipients being simultaneously listed on the general and the ESP waiting lists with a collective exclusively listed on the ESP list in terms of surrogates of the transplantation outcome. Methods: Total 151 eligible patients ≥ 65 years from Münster transplant Center, Germany, between 1999 and 2014 were included. Graft function, graft and patient survival were compared using surrogate markers of short- and long-term graft function. Patients were grouped according to their time of transplantation. Results: Recipients and donors in the newESP (nESP) cohort were significantly older (69.6 ± 3.5 years vs 67.1 ± 2 years, p